Compare Hims and Hers Health Inc (HIMS) vs Wayfair Inc (W) Price & Performance

HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.

The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.

Wayfair (W) trades at $105.13, up 0.63% with bullish technical signals and strong analyst support. The stock shows positive momentum with recent earnings beats and a consensus price target of $114.13. While revenue growth remains steady at $12.9B for 2026, the company continues to operate at a net loss margin of -2.49%, though operating cash flow improved to $665M. Recent developments include store expansion and new brand campaigns positioning for future growth.

Wayfair presents a growth opportunity with bullish technicals and analyst consensus, but faces fundamental challenges with persistent losses and high debt-to-asset ratio of 95.11%. The stock's upside potential depends on margin improvement and successful execution of retail expansion, while downside risks include competitive pressures and macroeconomic headwinds affecting consumer spending.